-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Equal-Weight on Amrize, Lowers Price Target to $40

Benzinga·10/19/2026 18:52:03
Barclays analyst Adam Seiden maintains Amrize (NYSE:AMRZ) with a Equal-Weight and lowers the price target from $55 to $40.